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Abstract
Bifidobacterium longum subsp. infantis is a common member of the intestinal microbiota in breast-fed infants and capable
of metabolizing human milk oligosaccharides (HMO). To investigate the bacterial response to different prebiotics, we
analyzed both cell wall associated and whole cell proteins in B. infantis. Proteins were identified by LC-MS/MS followed by
comparative proteomics to deduce the protein localization within the cell. Enzymes involved in the metabolism of lactose,
glucose, galactooligosaccharides, fructooligosaccharides and HMO were constitutively expressed exhibiting less than two-
fold change regardless of the sugar used. In contrast, enzymes in N-Acetylglucosamine and sucrose catabolism were
induced by HMO and fructans, respectively. Galactose-metabolizing enzymes phosphoglucomutase, UDP-glucose 4-
epimerase and UTP glucose-1-P uridylytransferase were expressed constitutively, while galactokinase and galactose-1-
phosphate uridylyltransferase, increased their expression three fold when HMO and lactose were used as substrates for cell
growth. Cell wall-associated proteomics also revealed ATP-dependent sugar transport systems associated with consumption
of different prebiotics. In addition, the expression of 16 glycosyl hydrolases revealed the complete metabolic route for each
substrate. Mucin, which possesses O-glycans that are structurally similar to HMO did not induced the expression of transport
proteins, hydrolysis or sugar metabolic pathway indicating B. infantis do not utilize these glycoconjugates.
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Introduction
Bifidobacterium longum subsp. infantis (B. infantis) is a common
member of the gastrointestinal tract (GIT) of breast-fed infants [1].
The establishment of a bifidobacterial-dominant microbiota has
received considerable attention regarding the development of the
infant [2]. One potential means by which specific bifidobacteria
succeed in colonizing the infant GIT is through prebiotic
enrichment by human milk oligosaccharides (HMO). Human
milk contains a significant amount of oligosaccharides (,15 g l21),
in contrast to bovine or formula milk [3,4]. HMO is a term that
collectively refers to approximately 200 different types of glycans
with diverse structures with a length smaller than 20 units of
carbohydrates [5,6]. These HMO are composed of hexoses (Hex)
and N-Acetylhexosamines (HexNAc) connected through b1-3 or
b1-4-glycosidic linkage with additional decoration of fucose (Fuc)
and N-Acetylneuraminic acid (NeuAc). Since the human host does
not have the enzymatic capacity to degrade these polymers, HMO
are not considered to be metabolized by infant, and have been
shown to arrive to the lower GIT [7]. HMO are considered part of
the innate immune system being used as decoy binding sites for
intestinal pathogens in the developing newborn [8]. Another role
is the enrichment of bifidobacteria in the GIT [9]. While B. infantis
and other bifidobacteria can actively utilize HMO as growth
substrate, other intestinal bacteria such as streptococci, entero-
cocci, E. coli and Clostridium sp. cannot use HMO as a carbon
source, emphasizing the bifidogenic potential of HMO [10].
Genome sequencing showed that B. infantis has a 40 kb gene
cluster, termed HMO cluster I, that encodes several enzymes and
transport systems required for HMO catabolism including a-
fucosidase, a-sialidase, b-hexosaminidase, b-galactosidase and the
ABC transport systems with six family 1, extracellular solute
binding proteins (SBPs) predicted to bind oligosaccharides [11].
These clusters of HMO-linked genes suggested a broader evolu-
tionary partnership among B. infantis, the developing infant and
human milk [12].
While current commercial prebiotics used in infant formulas,
such as fructooligosaccharides (FOS) and galactooligosaccharides
[13], have been shown to be bifidogenic, these commercial
prebiotics do not replicate the many different roles that HMO
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carry out in the developing infant. Since B. infantis displays several
mechanistic preferences for HMO consumption, this subspecies
represents a useful reference with which to assess the similarity of
commercial prebiotics to actual HMO. This in turn will aid in the
design of more effective prebiotics for use in infant formulas as well
as other conditions where very selective symbiotic applications
may be useful.
Global expression analysis of whole cell proteome by LC-MS/
MS can provide direct information relative to biological systems
such as metabolic pathways and regulatory networks. Despite the
advantages of whole cell proteomics, it is still challenging to
reliably identify cell wall associated (CWA) proteins due to the fact
that these proteins are often sequestered into the insoluble material
upon cell lysis. The lack of CWA proteins in proteomic analyses
results in significant loss of biological information since membrane
proteins or cell wall-anchored proteins also play important roles in
transport, exopolysaccharide production, hydrolysis of macromo-
lecules, and sensing of extracellular signals. Several proteomic
methods have been developed to specifically identify the CWA
proteins, including a 2-D gel based proteomic analysis followed by
fractionation [14,15,16], or labeling the cell surface proteins via
biotinylation followed by affinity capture [17,18]. An alternative
approach is the tryptic digestion of exposed epitopes on cell surface
proteins from intact cells in isotonic solution followed by the MS
analysis, which often called ‘‘shaving and shedding’’ [19,20].
In this study, we have investigated the impact of various
prebiotics on the proteomic expression profiles of B. infantis ATCC
15697. The microorganism was cultured with seven different
sugars and prebiotics including HMO and mucin, and more than
500 proteins were quantitatively identified enabling us to explore
the entire activity cell in a given substrate. Importantly, we
developed a proteomic analysis method that allowed reliable
determination of cell wall associated proteins. Through this
method, the expression of cell surface/membrane associated
proteins can be determined, maximizing the total protein
identification per cell. This has allowed a more comprehensive
comparison of the B. infantis physiology on these prebiotics.
Materials and Methods
Cell Culture
Bifidobacterium longum subsp. infantis ATCC 15697 was obtained
from the American Type Culture Collection (Manassas, VA).
Cultures were routinely maintained in de Mann-Rogosa-Sharp
(MRS) medium with no carbon source, and supplemented with
0.05% w/v L-cysteine (Sigma-Aldrich, St. Louis, MO), and 2%
w/v of either lactose (Sigma Aldrich, MO), purified HMO [21],
mucin from porcine stomach type III (Sigma Aldrich, MO), FOS
(raftilose Synergy 1, Orafti, Malvern, PA), inulin (raftiline HP,
Orafti, Malvern, PA) or GOS (Purimune, GTC Nutrition, Golden,
CO). These experiments were performed in duplicates. Cells were
anaerobically grown in a vinyl chamber (Coy Laboratory
Products, Grass Lake, MI) at 37uC for 24 h, in an atmosphere
consisting of 5% carbon dioxide, 5% hydrogen, and 90% nitrogen.
Optical density was assayed using a PowerWave microplate
spectrophotometer (BioTek Instruments, Inc., Winoosky, VT).
Due to the significant high turbidity of medium, cell growth on
mucin was evaluated separately. Mucin was autoclaved for 10
minutes and added on the media (50 ml) at a final concentration of
20 g l21. Cell growth was monitored by measuring optical density
of cell at 600 nm in a Shimadzu UV1601 spectrophotometer
(Shimadzu Scientific Instruments, Columbia MD). Cell cultures
supplemented with 2% (w/v) of glucose and 2% (w/v) of HMO
were obtained in similar conditions as control experiments.
Proteomic Sample Preparation
B. infantis cells were taken at the exponential phase of growth
and normalized at an OD of 1.0 by dilution or concentration.
After centrifugation to remove the spent media, 15 mL of cells
were washed three times with phosphate buffer saline (PBS)
followed by three more washes with urea buffer (8 M Urea/0.1 M
Tris, pH 8.5). The cell pellet was resuspended in 600 mL of urea
buffer, then mechanically disrupted by silica beads in a bead-
beater (FastPrep; QBiogene, Carlsbad, CA, USA) for eight cycles
of 30 s pulses and 30 s on ice. Upon centrifugation, the soluble
and the insoluble fractions were stored separately at 280uC until
further analysis.
For proteome analysis of the soluble fraction, a sample volume
containing 200 mg of protein was transferred to a new micro-
centrifuge tube and precipitated by the addition of ethanol (75%
(v/v) final) at 220uC. After centrifugation, the protein pellet was
resuspended in 100 mL of 0.1 M Tris/1 M urea buffer (pH 8.5).
Proteins were then digested using 5 mg of mass spectrometry grade
trypsin (Promega, Madison, WI, USA) overnight at 37uC. In order
to obtain the proteome of insoluble fraction, the insoluble cell
debris pellet was resuspended in 1 mL of PBS and washed three
times with urea buffer (8 M Urea/0.1 M Tris). The resulting pellet
was resuspended again in 100 mL of 0.1 M Tris/1M urea buffer
(pH 8.5) and digested with trypsin overnight. These two fractions,
soluble and CWA, were analyzed independently. The tryptic
peptides from two fractions were cleaned independently using
a Macro Trap with Peptide concentration and Desalting cartridge
(Michrom, Aurburn, CA, USA) according to the manufacturer’s
instructions. The resultant peptides were eluted in 98% acetoni-
trile in water and then dried prior to mass spectrometry analysis.
Mass Spectrometry Analysis
Peptides were reconstituted in water at concentrations corre-
sponding to between 40 and 200 ng of the original protein per
2 mL injection. Nano LC/MS and nano LC/MS/MS analyses
were performed on an Agilent HPLC-Chip Quadrupole Time-of-
Flight (Q-TOF) MS system equipped with a microwell plate
autosampler (maintained at 6uC), capillary sample loading pump,
nano pump, HPLC Chip/MS interface, and Agilent 6520 Q-TOF
MS detector. The chip used consisted of a 960.075-mm i.d.
enrichment column and a 15060.075-mm i.d. analytical column.
For sample loading, the capillary pump delivered 0.1% formic
acid in 3.0% acetonitrile/water (v/v) isocratically at 4.0 mL/min.
Following sample injection, a nano pump gradient was delivered
at 0.4 mL/min using (A) 0.1% formic acid in 3.0% acetonitrile/
water (v/v) and (B) 0.1% formic acid in 90.0% acetonitrile/water
(v/v). Samples were eluted with 0% B, 0.00–2.50 min; 0 to 16% B,
2.50–10.00 min; 16 to 44% B, 10.00–30.00 min; 44 to 100% B,
30.00–35.00 min; and 100% B, 35.00–45.00 min. This was
followed by equilibration at 0% B, 45.01–65.00 min. The drying
gas temperature was set at 325uC with a flow rate of 5.0 L/min
(2.5 L of filtered nitrogen gas and 2.5 L of filtered dry compressed
air).
Single-stage MS spectra were acquired in the positive ionization
mode over a mass range of m/z 400–3,000 with an acquisition
time of 1 s per spectrum. Mass correction was enabled using
reference masses of m/z 322.048, 622.029, 922.010, 1,221.991,
and 1,521.971 (ESI-TOF Calibrant Mix G1969-85000, Agilent
Technologies, Santa Clara, CA, USA).
Protein Identification
All MS/MS samples were analyzed by X! Tandem (GPM-XE
manager, ver. 2.2.1). X! Tandem was set up to search against the
proteome of B. infantis ATCC 15697 and common contaminant
Whole Cell Proteomics of B. infants
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proteins and searched with a fragment ion mass tolerance of
100 ppm. Oxidation of methionine was specified as a variable
modification in X! Tandem. The probability (log(e)) cutoff for
peptide assignment was set at 22. For the identification, two
conditions were required: (a) more than two unique peptides per
protein (Puniq$2) and (b) the probability cutoff for protein less than
26 (log(e)#26). Additional algorithms for protein identification
validated the protein identification results by X! Tandem. All
proteins identified by the X! Tandem were also assigned by the
peptide prophet [22] and protein prophet algorithm [23] with the
probability greater than 95% and 99% respectively. Since the
experiments were performed on biological duplicates an additional
rule was applied for the decision of protein expression. If a protein
was identified in one of the duplicates with high probability
(Puniq$2 and log(e)#26) then it was considered expressed. If
a protein had a log(e) value between 26 and24 and a Puniq$2 but
was found in both duplicates, it was also considered as expressed.
Protein Quantification
Relative amounts of protein in a sample were calculated by the
spectral counting method [24] using the proteome on lactose
grown cells as control. Normalized spectral abundance factor
(NSAF), which represented the relative abundance of protein in
a sample, was estimated from the total number of spectra used for
the identification of protein (SpC) and the number of aminoacids of
the protein (L). For accurate estimations, the relative amount of
protein was calculated only if the protein NSAF value was higher
than 1.0 or SpC of both proteins were $6.
Determination of Protein Localization
For this purpose, a scoring system was introduced that
employed the NSAF values of each protein in the soluble and
insoluble fraction (Table S1). If the protein was observed only at
the insoluble fraction, or the NSAF value of that protein in the
insoluble fraction was more than 3-fold higher than the NSAF
value of the same protein in the soluble fraction, the protein had
score +1. If the NSAF ratio was between 2- and 3-fold, a protein
was given a score of +0.5. When the NSAFs values of the same
protein in the soluble and insoluble fractions were within 2-fold
difference, the protein was given a score of zero. If the NSAF of
a protein at the soluble fraction was larger than that of at insoluble
fraction, the scores were attributed using the same criteria above,
however the values were negative. Once scores were determined,
values from the experiments with six different carbon sources were
averaged. If a protein had an average score between +0.5 to +1.0 it
was classified as a CWA protein. If the average score of a protein
was between 20.5 to 21.0, it was considered as cytosolic (CYT)
protein (Table S2).
Results
Cell Growth and Overall Protein Expression Profiles
B. infantis was able to utilize various mono and oligosaccharides
as growth substrates. The specific cell growth rates on GOS, FOS,
inulin, and HMO were in a range of 0.14,0.19 (hr21) which are
similar to that of glucose and lactose (Figure S1A). Mucin is a large
extracellular protein that is heavily glycosylated. The O-glycan
attached on the serine residue of mucin protein is composed of N-
Acetylgalactosamine, N-Acetylglucosamine, fucose, galactose and
sialic acid and has similar structures to HMO. It has been reported
that several intestinal bacteria are able to interact with the mucin
glycans [25,26]. Using mucin as the sole carbon source (Figure
S1B), an increase in OD600 was appreciated for B. infantis albeit
with the high initial cell density values.
The number of proteins identified from the soluble and
insoluble fractions is summarized in Table S3. Between 350 and
400 proteins were found in any individual sample grown on each
carbon source, and 100,170 proteins were commonly observed in
both the soluble and insoluble fractions in each sample. A sum
total of 540 proteins were identified during growth on the seven
different carbon sources among 2416 ORFs encoded by B. infantis.
Using the normalized spectrum abundance factor (NSAF) for
each protein (representing the normalized protein quantity in
a whole proteome of a single sample), quantitative expression
profiles of whole proteomes were compared between cells grown
on different carbon sources. While growth on most substrates
exhibited similar proteome expression patterns, growth on
galactooligosaccharides resulted in a separate cluster as witnessed
by hierarchical cluster analysis (Figure S2). In addition, the
correlation coefficients (Pearson’s product) between the GOS and
the other proteomes were low (0.6,0.8), indicating that the
protein expression observed during growth on GOS is significantly
different from growth on other tested substrates (Table S4).
Validation of Cell Wall Associated (CWA) Proteomics
Most proteins observed in current shotgun whole cell proteo-
mics experiments are cytosolic, while cell wall associated (CWA)
proteins (both cell wall attached and membrane proteins) remain
in the insoluble fraction with cell debris. Even if released from the
soluble fraction, they are often missed due to the low ionization
efficiency during MS analysis. Another constraint affecting their
detection is their low (and/or variable) abundance by comparison
to more readily obtained cytosolic proteins. To better understand
the expression of CWA proteins, the insoluble fraction obtained
after cell disruption was analyzed separately followed by the
extensive washing with a strong denaturing agent (8 M urea/0.1M
Tris). After removal of cytosolic proteins by washing, peptides
from the CWA proteins were released by tryptic digestion. Protein
localization was estimated by the quantitative ratio of their
amounts in the soluble fraction and insoluble fraction.
To validate this approach, the expression of representative
CWA proteins such as extracellular solute binding proteins (SBPs)
from B. infantis ATCC 15697 was examined [27]. These are
common lipoproteins often associated with the transport of various
ligands. Overall, 71 incidences of SBP expression were observed
from the proteome of B. infantis grown on the seven different
carbon sources. Among these, 23 cases of SBP expression were
only found in the insoluble fraction (Figure 1, black bar).
Moreover, 93% of the observed SBPs exhibited in average 2.9-
fold higher NSAF value in the insoluble fraction by comparison to
the soluble fraction (Figure 1). In addition to the SBPs, expression
of other known cell wall proteins was more clearly, or solely,
witnessed in the insoluble fraction. As shown in Table S5,
Blon_1259, a V5/Tpx-1 family protein was not identified on the
soluble fraction during growth on any carbon source, but it was
one of the most abundant proteins observed in insoluble fraction.
Also a cell surface protein involved in capsular exopolysaccharide
synthesis (Blon_2082) and the NlpA lipoprotein (Blon_1721)
exhibited 2 and 14 fold higher NSAF values in the insoluble
fractions than that observed in the soluble fractions respectively.
Therefore, by comparing the NSAF values of the soluble and
insoluble protein fractions this approach provided insight into the
cellular localization of each protein identified (Table 1 and 2). As
shown on Table 1, 196 proteins were classified as CWA proteins
and 93 were cytosolic (CYT) protein. However, the remaining 281
proteins could not be conclusively classified in either cellular
location (UI: unidentified). To further evaluate our method, the
number of a theoretical CWA protein was predicted bioinforma-
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tically [28]. Determination of transmembrane domains and signal
peptides by TMHMM 2.0 [29] and the SignalP 2.0 HMM [30]
indicated that 127 proteins are putative cell surface associated
proteins. Among this pool of proteins, 108 were validated as cell
wall associated by this proteomic approach. Only two of the cell
surface associated proteins identified bioinformatically were
categorized as cytosolic. In addition, 17 out of 127 theoretical
surface proteins were found in the UI group. Thus while 281
proteins were classified into this group by the above scoring
criteria, the latter results on putative cell surface proteins suggests
that the UI group is more likely to contain cytosolic proteins.
Carbohydrate Metabolism
Proteins involved in carbohydrate metabolism in B. infantis are
summarized in Figure 2. Enzymes in the bifid shunt and glycolytic
pathway, which are common to the utilization of various carbon
sources, exhibited constitutive expression on the substrates used in
this study (Figure S3). When compared to lactose-grown cells, the
amount of each protein in these pathways varied less than two-fold
among the different substrates. Interestingly, the genome of B.
infantis ATCC 15697 indicates that several enzymes have
isozymes. For example it contains seven genes encoding putative
phosphoglycerate mutases, but only the expression of a single gene
was appreciated, Blon_2152 (Figure S3).
B. infantis metabolizes galactose through the Leloir pathway.
Proteins of this pathway were observed in the proteomes of cells
grown on all seven carbon sources, albeit their amounts varied. As
shown in Figure 2A, galactokinase (galK: Blon_2062), Gal-1-P
uridylyltransferase (galT: Blon_2063) and UDP-glc epimerase
(galE: Blon_0538) were highly expressed on lactose, HMO and
FOS. However, the alternative galE (Blon_2171) and phosphoglu-
comutase (pgm: Blon_2184) were constitutively expressed across all
substrates.
N-Acetylglucosamine (GlcNAc) is one of the major constituents
of HMO. To metabolize this monosaccharide, B. infantis possibly
converts GlcNAc to fructose-6-P (Fru-6-P) by deacetylation
followed by deamidation. GalNAc is another hexosamine found
in O-linked glycans, and it could be first isomerized to GlcNAc by
an N-Acetylglucosamine 6-phosphate 2-epimerase (nanE:
Blon_0645). The acetyl and amine groups of GlcNAc-6-P could
then be removed by GlcNAc-6-P deacetylase (nagA: Blon_0882)
and glucosamine-6-P isomerase (nagB: Blon_0881), respectively.
Figure 1. Distribution of the NSAF ratio of each SBP between soluble and insoluble fraction (grey bars; yNSAFinsol/NSAFsol). White
bars (soluble: left corner) and black bars (insoluble: right corner) indicate the number of SBP observed solely in soluble and insoluble fraction,
respectively.
doi:10.1371/journal.pone.0057535.g001
Table 1. Distribution of B. infantis proteins in cell wall or cytosolic fractions.
Location Proteins identifieda Theoretical cell wall/membrane associated proteinsb
Cell wall association (CWA) 196 108
Cytosol (CYT) 93 2
Unidentified (UI) 281 17
Total 540 127
aNumber of the protein for which the location was determined by the score system (See Materials and Methods).
bTheoretical cell wall/membrane associated proteins were determined by the Signal prediction by SignalP 2.0 HMM and the transmembrane helices prediction by
TMHMM2.0. Bioinformatic information including pfam classification was obtained from the Integrated Microbial Genomes database.
doi:10.1371/journal.pone.0057535.t001
Whole Cell Proteomics of B. infants
PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e57535
These three enzymes are expressed significantly only when B.
infantis was cultivated on HMO, suggesting the specific induction
of catabolic pathway for HexNAc (Figure 2B).
While the proteins in the main glycolytic pathway were
constitutively expressed, enzymes involved in pyruvate fermenta-
tion changed their expression level depending on the carbon
source. As shown in Figure 2C, pyruvate is reduced to lactate by
lactate dehydrogenase (ldh: Blon_0840) with the regeneration of
NAD+. Alternatively, pyruvate is converted to formate and acetate
by the combination of pyruvate-formate lyase (pfl: Blon_1715)
cleaving pyruvate to formate and acetyl CoA, and acetate kinase
(ack: Blon_1731) converting acetyl CoA to acetate with the
production of ATP. Expression of acetate kinase and formate C-
acetyltransferse was consistent across all growth substrates.
However, lactate dehydrogenase exhibited a different expression
pattern depending on the carbon sources used. During growth on
lactose or FOS, the amounts of LDH were 2 to 3.5-fold smaller
than those when B. infantis grew on glucose, GOS, inulin and
HMO. Interestingly, LDH was expressed 5.5-fold more on mucin
compared to lactose. Alternative route enzymes that can produce
acetyl CoA from pyruvate, i.e. pyruvate dehydrogenase or
pyruvate oxidase, were not expressed in any of the proteomes
(data not shown).
Inulin and FOS are fructose polymers with different degrees of
polymerization (DP). When FOS and inulin were used as carbon
sources, a specific glycosyl hydrolase (GH) was induced (Fig-
ure 2D). Blon_0128 is a family 13 GH annotated as a sucrose
phosphorylase. These enzymes cleave sucrose to glucose and
fructose-6-phosphate. The NSAF of Blon_0128 in the soluble
fraction is higher than insoluble fraction suggesting a cytosolic
localization. Two family 32 GH proteins (Blon_2056 and
Blon_0787) were also expressed exclusively on FOS and/or
inulin. Known activities of the family 32 GH includes inulinase
(EC:3.2.1.7), levanase (EC:3.2.1.65), and exo-inulinase
(EC:3.2.1.80). While Blon_0128 and Blon_2056 were expressed
on both inulin and FOS, the expression of Blon_0787 was
observed only in the proteome of FOS grown cells. The
localization of Blon_0787 was determined in the UI group but is
most likely a cytosolic protein.
Solute Binding Proteins (SBP)
Extracellular SBPs are typically linked to specific ABC transport
systems consisting also in two inner membrane transporter
components and an ATPase. The B. infantis genome contains 39
SBPs of three different classes: Family 1, 3, and 5 [31]. In
particular, Family 1 extracellular SBPs are thought to be
Figure 2. Central metabolic pathways reconstructed from proteomic datasets. Sugar substrates are presented inside the red boxes.
Pathways regulated or induced by the presence of a specific sugar are indicated by colored background and their expressions on different sugars are
presented next to the pathway as bar graphs: (a) Leloir pathway, (b) HexNAc catabolic pathway, (c) pyruvate fermentation pathway, (d) FOS/Inulin
glycosyl hydrolase. The relative amounts of enzymes involved in the bifid shunt are presented in Figure S3. Numbers in the parenthesis next to the
enzyme are the locus tag of each protein expressed.
doi:10.1371/journal.pone.0057535.g002
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responsible to the translocation of oligosaccharides [31]. As shown
in Figure 3, different SBPs were expressed during growth of B.
infantis on different carbohydrates. As indicated above, all Family 1
SBPs were categorized as CWA.
When B. infantis was grown on GOS, the amounts of SBP
Blon_2414 were notably high, and FOS and inulin induced the
expression of Blon_2061. In the latter case, low amounts of other
SBPs were also observed, however, the expression of Blon_2061
was 10,20 fold higher than the others. When HMO was added
Figure 3. The expression of Family 1 extracellular SBPs on different carbon sources. The quantitative expression of each SBP is described
by NSAF value. Black and gray bars indicate the NSAF values obtained in insoluble and soluble fraction, respectively. Box indicates the SBPs in the
HMO cluster.
doi:10.1371/journal.pone.0057535.g003
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on the media, SBPs Blon_2344 and Blon_2347 were mainly
expressed. Significant expression of SBPs was not observed when
B. infantis grew on glucose and lactose. Interestingly, mucin, whose
glycan structure is similar to HMO, did not induce the expression
of any of Family 1 SBPs.
B. infantis has seven Family 3 and nine Family 5 SBPs, with
broad affinity for di- and oligopeptides. Family 3 SBPs were
actively expressed throughout cell growth (Figure S4). Blon_0747
and Blon_0760 were commonly expressed regardless of carbon
sources. Blon_2021 was induced by glucose, lactose, GOS, FOS
and mucin but not HMO or inulin. Expression of Blon_0710 and
Blon_2022 was observed when B. infantis was cultivated on glucose
and lactose. Among Family 5 SBPs, Blon_0922 was highly
expressed on all carbon sources examined. The amount of
Blon_0922 expression was consistent and very high: it was one
of the most highly expressed SBPs on all conditions (with the
exception of Blon_2061 during growth on inulin). NSAF of
Blon_0834 was high but specific in GOS proteome. Blon_0053
and Blon_2419 appeared to be expressed constitutively across all
substrates but at a low level.
HMO Cluster I Protein Expression
B. infantis contains a 43 kb cluster (HMO cluster I) that encodes
genes for the catabolism of HMO ([11]; Figure 4A). During
growth on HMO, expression of all different glycosyl hydrolases
required for the degradation of HMO was observed. A b-
galactosidase (Blon_2334) was expressed on all seven proteomes
but the expression during growth on GOS was 2,3 times higher
than that of other carbon sources (Figure 4B). The expression of
the a-1/3,4 fucosidase Blon_2336 [32] was observed on lactose,
FOS, inulin, and HMO indicating a more constitutive expression
(Figure 4C). Interestingly, the expression of an a-sialidase
Blon_2348 [33] was exclusive to the HMO proteome
(Figure 4D). The expression of a b-hexosaminidase (Blon_2355)
was observed only during growth on HMO and inulin (Figure 4E).
Using the scoring criteria described above, the cellular location of
b-galactosidase and b-hexosaminidase were inconclusive however
the NSAF of these proteins in the insoluble fraction was more than
2 times higher than those at soluble fraction suggesting possible
membrane association. As described in Figure 4A, putative HMO-
related transporter SBPs Blon_2344 and Blon_2347 were adjacent
to genes for two inner membrane transporter components, while
SBPs Blon_2350, Blon_2351, Blon_2352, and Blon_2354 were
positioned elsewhere in the HMO Cluster 1 without adjacent
permease components. Protein from Blon_2344 was identified
during growth on most of carbon sources but its amount was low
(Figure 4F). During growth on HMO, however, expression of
Blon_2344 was increased significantly. Blon_2347 was only
expressed when cultivated on HMO (Figure 4G). Other Family
1 SBPs in the HMO Cluster 1 were determined (if detected at all)
in small amounts, suggesting a basal level expression (Figure 4H-
K). Proteins Blon_2338, Blon_2339, and Blon_2340 are also
located on the HMO cluster 1, and they were expressed
constitutively (Figure 4L–N). Their localization appears to be
cytosolic however their function and/or relationship to HMO
utilization are unclear.
Glycosyl Hydrolases (GH) and Glycosyltransferases [34]
Glycosyl hydrolases (GHs) and glycosyltransferases (GTs) are
important enzymes that degrade or synthesize oligosaccharides
respectively. Expression of 16 GHs was observed throughout the
proteomes obtained (Figure 5). Blon_1905 is Family 1 GH,
presumably a b-glucosidase, which was constitutively and highly
expressed during growth on all of the different carbon sources.
Expressions of four different b-galactosidases were identified.
Blon_2334 (GH Family 2) and Blon_2016 (GH Family 42) were
constitutively and highly expressed on all substrates, in order
with previous observations [35]. Blon_0268 (GH2) and
Blon_2416 (GH42) were specifically found during growth on
GOS. Interestingly, NSAFs of Blon_2334, Blon_0268, and
Blon_2016 in the insoluble fraction were two-fold higher than
those in soluble fraction, suggesting a cell wall association of
these GH activities. Three other GHs (Blon_2056, Blon_0787
and Blon_0128) were specifically expressed when B. infantis was
grown on FOS and inulin. Blon_2056 and Blon_0787 are GH
Family 32 proteins, suggested to be exo-inulinases [36]. The
cellular location of these two enzymes was not conclusively
determined. Blon_0128 is a GH Family 13 protein, annotated
as sucrose phosphorylase, and was classified here as a cytosolic
protein. In addition to Blon_2355 in the HMO cluster I, B.
infantis has a second b- hexosaminidase (Blon_0732; GH20).
While Blon_2355 was specifically expressed during growth on
HMO and inulin and was cell wall-associated, Blon_0732 was
constitutively expressed and is more likely cytosolic showing
a similar or lower NSAF in the insoluble fraction. Finally, the
expression of Family 13 (Blon_2456) and Family 36 (Blon_2460)
GHs were found in GOS proteome however their amounts
were relatively low compare to other GHs.
Enzymes involved in the glycan synthesis and exopolysac-
charide production (Figure 5) were also identified. Blon_2246
and Blon_1761 are 4-a-glucanotransferase and 1,4-a-glucan 6-
branching enzymes respectively, and both were consistently
expressed regardless of the carbon source. An a-glucanpho-
sphorylase (Blon_0070, GT family 35) which reversibly produces
glucose-1-P from glucan was also constitutively expressed on all
substrates. The NSAF ratio between soluble and insoluble
fraction is close to 1.0-fold or less suggesting intracellular
localization. Nine glycosyl transferases and one extracellular
polysaccharide synthesis protein were identified and found to be
highly enriched in the insoluble fraction suggesting a cell surface
association. Among them, Blon_2082 is predicted to participate
in the synthesis of exopolysaccharide, and it was found to be
present in all of the proteomes analyzed regardless of the
growth substrate. With the exception of Blon_2381, other CWA
glycosyl transferases were expressed only during growth on
GOS (Figure 5).
Hypothetical Proteins
There are 845 hypothetical or unknown proteins in the B.
infantis ATCC 15697 genome, which represent 35% of total ORFs
[11]. Among these proteins, we observed expression of 63 proteins
across seven different sugars (Figure S5). Most were cytosolic
proteins expressed without significant variation in abundance
among the growth substrates used. Remarkably, some of the
cytosolic hypothetical proteins were highly expressed as high as
glyceraldehyde-3-P dehydrogenase.
A notable result was witnessed regarding the expression of
hypothetical CWA proteins. When B. infantis was grown on GOS,
hypothetical CWA proteins were highly induced and/or signifi-
cantly overexpressed. 26 hypothetical CWA proteins were
observed from the proteome during growth on GOS while 8 to
17 hypothetical CWA proteins were found in the proteomes
during growth on the other substrates, Furthermore, the expressed
amount of these 26 CWA proteins observed on the GOS
proteome was significantly higher than those from other substrates
(Figure S5).
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Figure 4. The expression of proteins in HMO cluster in B. infantis during growth on different prebiotics. (a) Graphical display of genes in
HMO cluster. Proteins involved in the HMO translocation and degradation are noted with the locus tag under the gene. Sets of genes inside the red
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Discussion
Mass spectrometry analysis of whole cell proteins is a common
method to directly obtain information on the existing proteins
within a biological system thus enabling the prediction of active
metabolic pathways or regulatory networks. Because proteins have
a slower turnover rate than mRNA and metabolites, proteomics
can provide a more stable snapshot of cell metabolic system at the
moment when cells were collected. While the cytosolic proteins are
readily analyzed quantitatively and qualitatively, analysis of CWA
proteins is still challenging due to the difficulties in fractionation
and purification. ‘‘Shaving’’ the surface exposed proteins of intact
cells is promising particularly in high-throughput analysis of whole
cell proteome [19,28,37]. However, sequestering of cytosolic
proteins into the insoluble fraction is often observed and it biases
cell surface proteomics significantly [38,39,40]. Indeed, when we
applied the shaving reaction to the intact cell of B. infantis, the
proteomic results were the same as those obtained from cytosolic
fraction (data not shown).
To improve the determination of the CWA proteome, two
approaches were employed for B. infantis. Instead of intact cells, we
disrupted B. infantis cells first and the remaining cytosolic proteins,
box are the transport systems that comprise a Family 1 extracellular SBP and two inner-membrane components. Bars represent the relative amounts
of each protein in different carbon sources. Black and gray bars indicate the NSAF values in the soluble and insoluble fraction, respectively. (b),(e)
are the glycosyl hydrolases for HMO degradation. (f),(k) are the Family 1 SBPs and (l),(n) are the proteins whose the amount was high but the role
in HMO metabolism is not well known.
doi:10.1371/journal.pone.0057535.g004
Figure 5. The expression of glycosyl hydrolases and glycosyltransferases in B. infantis during growth on different prebiotics. The
amount of protein expressed scaled by color from green to red as shown in the legend. Gray indicates that the expression was not detected. Left and
right panel of heat map represent the expression of protein in soluble and insoluble fraction, respectively. CWA protein was determined by the NSAF
ratio between soluble and insoluble faction (NSAFinsol/NSAFsol$2.5).
doi:10.1371/journal.pone.0057535.g005
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as well as cellular exopolysaccharide, were eliminated with
extensive washes using a strong denaturing buffer (8M urea/
0.1M Tris). Then, the CWA proteins were cleaved with trypsin
from the cell debris obtained from the insoluble fraction. Despite
the enhanced number of cell wall proteins observed using this
approach, highly expressed cytosolic proteins (i.e. enolase or
pyruvate kinase) were still found as major proteins in the insoluble
fraction (Table S6). Therefore we ascribed cell wall association by
the relative ratio of protein abundance between the soluble and
insoluble fractions. As shown in Figure 1, most of the extracellular
SBPs exhibited more than a three-fold increase in protein
abundance in the insoluble fraction and 23 SBPs were observed
only in insoluble fraction. Meanwhile the cytosolic proteins
exhibited the similar or less relative abundance in the insoluble
fraction. For example, the relative abundance of enolase and
pyruvate kinase was 1.5560.43 and 21.1460.29, respectively,
suggesting these enzymes should not be classified as CWA
proteins.
The determination of protein localization using the NSAF ratio
of proteins observed in soluble and insoluble fractions was
validated by comparison with the bioinformatic properties of the
target proteins. Among the 127 proteins identified that possessed
transmembrane domains or signal peptide sequences, 108 of them
were determined as CWA proteins. Only two theoretical cell wall/
membrane proteins were determined exclusively as cytosolic
(Table 1). Of the 196 proteins that were classified as CWA
proteins, 88 proteins did not present any bioinformatic evidence
for the cell wall/membrane association. However, cell wall
association defined here is not necessarily the indication of protein
integration into the cell membrane or extracellular position per se.
Since the tryptic digestion is performed after the disruption of cell,
proteins associated with the inner part of cell membrane may also
be captured.
It has been shown that B. infantis can utilize various prebiotics
[27,41,42,43]. However, the cognate pathways that metabolize
these substrates have not been investigated. Whole cell proteomics
enabled us to determine the expression of key cellular proteins
involved in the catabolic process for different prebiotics (Figure 6).
HMO, GOS, FOS and inulin are oligosaccharides with different
chemistries and degrees of polymerization. In particular, HMO is
a heterologous mixture of more than 200 different structural and
compositional isomers [5]. In B. infantis, complete hydrolysis of
HMO to monosaccharides appears to occur in the cytosol after
translocation [9]. As shown in Figure 3, induction of specific
Family 1 SBPs during growth on different oligosaccharides
suggests these are transported inside the cells by associated ABC
transport systems. Family 1 SBPs are induced during growth on
HMO bind different isomers of these molecules and we previously
observed a similar SBP expression pattern via proteomic analysis
and transcriptomic analysis [27]. In addition, two Family 1 SBPs,
a b-hexosaminidase, an a-fucosidase and an a-sialidase from the
main HMO cluster were expressed only when B. infantis grew on
HMO as the sole carbon source. Proteomics also suggested that
both inulin and FOS are imported by the transporter associated to
the Family 1 SBP Blon_2061, which are then cleaved by two exo-
inulinases (Blon_2056 & Blon_0787), with the help of a sucrose
phosphorylase (Blon_0128) to degrade the polymer to hexose
phosphate for further metabolism. GOS appears to have specific
transport and hydrolysis system. Blon_2414 was the only Family 1
SBPs expressed during growth on GOS, and the adjacent b-
galactosidase (Blon_2416) was also induced by GOS.
B. infantis contains both constitutively expressed and inducible
glycosyl hydrolases (Figure 6). While a set of GHs was expressed in
association with specific oligosaccharides, b-galactosidases
Blon_2334 and 2016, b-hexosaminidase Blon_0732 and an
oligosaccharide hydrolase (Family 13 GH: Blon_1740) were to
a different extent stably expressed in all carbon sources. The a1-3/
4 fucosidase Blon_2336 was highly expressed during growth on
HMO. The activity of several of these enzymes on HMO has been
recently explored [32,33,35,44]. A series of b-galactosidases, as
well as Family 13 GHs, were expressed when B. infantis was grown
on GOS (Figure 5). Most of the GHs identified were determined to
be cytosolic (Figure 5). However, two b-galactosidases (Blon_0268
and Blon_2416) and one a-galactosidase (Blon_2460), which were
expressed only grown on GOS, were classified as CWA proteins.
The lack of transmembrane domain or signal peptide sequence
might imply the proximity to the cell wall/membrane inside the
cytosol instead of extracellular display.
After hydrolysis of oligosaccharides, the constituent monosac-
charides or their phosphorylated forms are further metabolized
through common central pathways. Glucose and fructose directly
enter the bifidus shunt, for which the cognate enzymes appear to
be constitutively expressed (Figure 2). Galactose enters the central
carbon metabolic pathways via the Leloir pathway. The enzymes
in this pathway were constitutively expressed in B. infantis, but
interestingly GalK and GalE were up-regulated in the presence of
sugars that contain galactose (i.e. lactose, GOS or HMO).
Enzymes that convert GlcNAc to fructose-6-P were only expressed
when HMO was in the media suggesting their induction by
GlcNAc.
Mucin is a highly polymerized protein that contains O-linked
glycans at specific serine or threonine residues. Because mucin O-
glycans are structurally similar to HMO, it is likely a similar set of
enzymes metabolize these substrates in bifidobacteria. However,
growth on mucin by B. infantis did not lead to a similar proteomic
profile compared to growth on HMO, suggesting no hydrolysis or
metabolism of these O-glycans. In turn B. infantis is able to cleave
and consume N-linked glycans [45]. In contrast, Bifidobacterium
bifidum PRL2010 can metabolize both HMO and mucin [26] by
similar mechanisms including membrane glycosyl hydrolases and
permeases [26], as previously determined by proteomics and
microarrays. Thus B. bifidum and B. infantis represent convergent
strategies for HMO consumption in the infant gut microbiota [9].
The main end products of bifidobacterial metabolism are
usually lactic acid, acetate and formate [11]. Acetate kinase (ack)
converts acetyl-P to acetate and ATP (Figure 2C). This enzyme
was constitutively expressed across the growth substrates used.
Conversely, lactate dehydrogenase (ldh), producing lactate from
pyruvate with the conversion of NADH to NAD+, was differen-
tially expressed depending on the carbon source. Interestingly, this
enzyme was present at lower levels during growth on FOS and
inulin, and this correlates with higher acetate:lactate ratios during
growth on these prebiotics [46]. Production of certain short chain
fatty acids by commensal bacteria has been shown to have
protective effects against pathogens [47]. The higher amount of ldh
protein observed for certain growth substrates such as GOS and
HMO implies higher levels of lactate as an end-product.
It has been reported that species of Bifidobacterium, including B.
infantis, are able to produce exopolysaccharides (EPS) and their
structures have been elucidated [48,49,50,51,52,53,54]. Indeed,
Tone-Shimokawa et al revealed that the EPS produced by the B.
infantis ATCC 15697 (formally referred as B. infantis Reuteri
ATCC 15697) is a galactose polymer with the structure of b-D-
Gal-(1R3)-a-D-Gal [55]. Important functions in host-microbe
interactions such as stress tolerance and immunomodulation have
been recently determined for B. breve EPS [56]. In addition,
bifidobacterial genomes indicate they can synthesize storage
polysaccharides such as glucan or glycogen [11]. Three enzymes
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in B. infantis, a-glucan phosphorylase, 1,4-a-glucan 6-branching
enzyme, and 4-a-glucanotransferase that might synthesize (or
reversibly degrade) a-glucans were constitutively expressed
(Figure 5). Interestingly, their expression was classified as cytosolic
while other glycosyl transferases [34] were found associated the
CWA fraction. Blon_2082, a lipopolysaccharide biosynthesis
protein was highly and constitutively expressed on cell surface
regardless of sugar. Expressions of the additional nine GTs were
identified in the insoluble fraction. Eight of them, which included
more than three different families of GT, were exclusively or
highly expressed in the presence of GOS in the medium.
In conclusion, this study provides a global picture of the
consumption of important prebiotics such as HMO, GOS and
FOS by B. infantis ATCC 15697 with a focus on the proteins
deployed for catabolism of these sugars. Using an improved
proteomics approach to specifically determine cell-wall associated
from cytosolic proteins, we have shown that in general utilization
of these substrates occurs via specific transport mechanisms,
defined by specific solute binding proteins, and glycosyl hydrolases
that convert these oligosaccharides into monosaccharides. While
several known proteins in the HMO cluster I were only expressed
during bacterial growth on these substrates, GOS responses
included an important number of hypothetical proteins, as well as
individual b-galactosidases and SBPs.
Supporting Information
Figure S1 Cell growth profile of B. infantis ATCC 15697
grown on different carbon sources. (A) B. infantis was
cultivated in 15 ml of ZMB media and 2% (w/v) of carbon
sources. Optical density (OD) was measured automatically at
600 nm without dilution. Carbon sources and their symbol were
noted in the legend. LAC; lactose, GLC; glucose, FOS;
fructooligosaccharide, INL; inulin, HMO; human milk oligosac-
charide, GOS; galactooligosaccharides. (B) B. infantis was cultivat-
ed in 25 ml of M17 media with 2% (w/v) of glucose, mucin and
HMO as a carbon source. Optical density of cell was measured
with appropriate dilution within the range of 0.3,0.5 at the
wavelength of 600 nm.
(PDF)
Figure S2 Hierarchical cluster analysis of protein
expression profile of B. infantis grown on different
carbon sources. Similarity was calculated by Euclidian distance
and the cluster was built by the Average linkage method. LAC,
lactose; GLC, glucose; FOS, fructooligosaccharides; INL, inulin;
HMO, human milk oligosaccharides; MUC, mucin; GOS,
galactooligosaccharides.
(PDF)
Figure S3 Expression of proteins involved in the
glycolysis and the bifid shunt. The comparative proteomics
using the lactose proteome as control suggested that the expression
level was changed less than two fold showing constitutive
expression regardless of carbon sources. LAC, lactose; GLC,
glucose; FOS, fructooligosaccharides; INL, inulin; HMO, human
milk oligosaccharides; MUC, mucin; GOS, galactooligosacchar-
ides.
(PDF)
Figure S4 Expression of (a) family 3 and (b) family 5
extracellular solute binding (SBP) proteins. Gray and block bars
represent the NSAF values obtained from the proteome of the cell
wall associated and the cytosolic fraction, respectively. LAC,
lactose; GLC, glucose; FOS, fructooligosaccharides; INL, inulin;
HMO, human milk oligosaccharides; MUC, mucin; GOS,
galactooligosaccharides.
(PDF)
Figure 6. Schematic diagram of the potential metabolic pathways for different prebiotic consumption in B. infantis. The catabolic
pathways for monosaccharides were detailed in Figure 2. Bold and curved arrows indicate the flow of oligosaccharide.
doi:10.1371/journal.pone.0057535.g006
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Figure S5 Expression of hypothetical proteins. Soluble
and insoluble indicate the fractions where the proteins are located:
cell wall associated (CWA), cytosolic (CYT), or shared, as
described in Methods and materials. SigP and TM stand for the
presence of signal peptide sequence and the number of trans-
membrane domains, respectively. LAC, lactose; GLC, glucose;
FOS, fructooligosaccharides; INL, inulin; HMO, human milk
oligosaccharides; MUC, mucin; GOS, galactooligosaccharides.
(PDF)
Table S1 The score system to determine the protein localization.
(PDF)
Table S2 The range of a score that determine the protein
location.
(PDF)
Table S3 Number of proteins expressed in the B. infantis
proteome across different prebiotics.
(PDF)
Table S4 Linear correlation coefficients (Pearson’s Product)
between two proteomes.
(PDF)
Table S5 Normalized protein amounts of representative cell
surface associated proteins in soluble and insoluble fraction.
(PDF)
Table S6 List of top 30 most expressed proteins in (a) soluble
and (b) insoluble fractions. The rank was determined by the sum of
all NSAF values of each carbon sources. The CWA proteins were
marked by gray area. Ribosomal proteins were excluded in the list.
LAC; lactose, GLC; glucose, GOS; galactooligosaccharides, FOS;
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